NCT06368713

Brief Summary

This study will investigate the impact of exercise on gastrointestinal function in peritoneal dialysis patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
132

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 7, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 16, 2024

Status Verified

April 1, 2024

Enrollment Period

1.3 years

First QC Date

April 7, 2024

Last Update Submit

April 11, 2024

Conditions

Keywords

Peritoneal DialysisExercise interventionGastrointestinal functionTelehealth

Outcome Measures

Primary Outcomes (1)

  • Change in GIQLI

    The Gastrointestinal Quality of Life Index is a 36-item questionnaire assessing the impact of gastrointestinal symptoms and diseases on daily life. The GIQLI includes five domains: gastrointestinal symptoms (19 items), emotional status (5 items), physical function (7 items), social function (4 items), and medical inconvenience (1 item). Each item is scored from 0 to 4, with a total score ranging from 0 to 144. Higher scores indicate better quality of life.

    Patients are required to complete the questionnaire at baseline, 2 weeks, 4 weeks, 2 months, and 3 months after the start of the intervention.

Secondary Outcomes (5)

  • Change in GSRS

    Patients are also required to complete the questionnaire at baseline, 2 weeks, 4 weeks, 2 months, and 3 months after the start of the intervention.

  • Change in PAC-SYM

    Patients are required to complete the questionnaire at baseline, 2 weeks, 4 weeks, 2 months, and 3 months after the start of the intervention.

  • Change in 6-MWT

    Measurements are taken before the start of the intervention, 2 weeks and 3 months after the intervention.

  • Change in SGA

    Patients are required to complete the SGA scale at the baseline and 3 months after the intervention.

  • Change in measured Gastrointestinal Hormones

    Blood samples will be collected at the baseline and and 3 months the intervention.

Study Arms (2)

Exercise intervention group

EXPERIMENTAL

The exercise intervention group will receive guidance for exercises and participate in remote exercise sessions monitored.

Behavioral: Exercise

Control group

NO INTERVENTION

The control group will not receive exercise intervention.

Interventions

ExerciseBEHAVIORAL

* Frequency: Exercise sessions will occur no less than three times per week. * Intensity: The intensity will be based on a rating of perceived exertion score ranging from 12 to 16 on a scale of 6 to 20. * Exercise duration: Each exercise session will last approximately 30 minutes. * Exercise Type:The exercise regimen will include aerobic exercise, resistance exercise, and flexibility training.

Exercise intervention group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have undergone peritoneal dialysis for more than 3 months.
  • Age between 18 and 65 years.
  • Possession of a smartphone and proficiency in its usage.
  • Willingness to provide voluntary informed consent by signing the consent form.

You may not qualify if:

  • Recent systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg, or systolic blood pressure ≤90 mmHg or diastolic blood pressure ≤60 mmHg within the past week.
  • Presence of severe cardiovascular diseases, including but not limited to:
  • Heart failure classified as New York Heart Association (NYHA) functional grade IV-V.
  • Severe arrhythmias such as third-degree atrioventricular block, sick sinus syndrome, paroxysmal supraventricular tachycardia, or ventricular tachycardia.
  • Unstable angina.
  • Pulmonary arterial hypertension with pulmonary arterial pressure ≥25 mmHg.
  • Severe pericardial effusion, valve stenosis, hypertrophic cardiomyopathy, or aortic dissection.
  • Severe pulmonary diseases, including but not limited to:
  • Severe chronic obstructive pulmonary disease (COPD).
  • Pulmonary embolism.
  • Lung cancer.
  • Severe pulmonary infection.
  • Presence of deep venous thrombosis.
  • Severe neurological, muscular, bone, or joint diseases that hinder compliance with exercise.
  • Participation in other concurrent exercise programs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital,School of Medicine, University of Electronic Science and Technology of China

Chengdu, Sichuan, 610000, China

RECRUITING

Related Publications (30)

  • ROB CG, RICHARDSON JS. Peritoneal dialysis. Lancet. 1947 Feb 1;1(6440):195. doi: 10.1016/s0140-6736(47)91172-0. No abstract available.

    PMID: 20341549BACKGROUND
  • Zhang P, Wang X, Li S, Cao X, Zou J, Fang Y, Shi Y, Xiang F, Shen B, Li Y, Fang B, Zhang Y, Guo R, Lv Q, Zhang L, Lu Y, Wang Y, Yu J, Xie Y, Wang R, Chen X, Yu J, Zhang Z, He J, Zhan J, Lv W, Nie Y, Cai J, Xu X, Hu J, Zhang Q, Gao T, Jiang X, Tan X, Xue N, Wang Y, Ren Y, Wang L, Zhang H, Ning Y, Chen J, Zhang L, Jin S, Ren F, Ehrlich SD, Zhao L, Ding X. Metagenome-wide analysis uncovers gut microbial signatures and implicates taxon-specific functions in end-stage renal disease. Genome Biol. 2023 Oct 12;24(1):226. doi: 10.1186/s13059-023-03056-y.

    PMID: 37828586BACKGROUND
  • Jiang S, Xie S, Lv D, Wang P, He H, Zhang T, Zhou Y, Lin Q, Zhou H, Jiang J, Nie J, Hou F, Chen Y. Alteration of the gut microbiota in Chinese population with chronic kidney disease. Sci Rep. 2017 Jun 6;7(1):2870. doi: 10.1038/s41598-017-02989-2.

    PMID: 28588309BACKGROUND
  • Hirako M, Kamiya T, Misu N, Kobayashi Y, Adachi H, Shikano M, Matsuhisa E, Kimura G. Impaired gastric motility and its relationship to gastrointestinal symptoms in patients with chronic renal failure. J Gastroenterol. 2005 Dec;40(12):1116-22. doi: 10.1007/s00535-005-1709-6.

    PMID: 16378175BACKGROUND
  • Yi C, Wang X, Ye H, Lin J, Yang X. Patient-reported gastrointestinal symptoms in patients with peritoneal dialysis: the prevalence, influence factors and association with quality of life. BMC Nephrol. 2022 Mar 9;23(1):99. doi: 10.1186/s12882-022-02723-9.

    PMID: 35264119BACKGROUND
  • Duncanson E, Chur-Hansen A, Jesudason S. Psychosocial consequences of gastrointestinal symptoms and dietary changes in people receiving automated peritoneal dialysis. J Ren Care. 2019 Mar;45(1):41-50. doi: 10.1111/jorc.12265. Epub 2018 Dec 25.

    PMID: 30585418BACKGROUND
  • Strid H, Simren M, Johansson AC, Svedlund J, Samuelsson O, Bjornsson ES. The prevalence of gastrointestinal symptoms in patients with chronic renal failure is increased and associated with impaired psychological general well-being. Nephrol Dial Transplant. 2002 Aug;17(8):1434-9. doi: 10.1093/ndt/17.8.1434.

    PMID: 12147791BACKGROUND
  • Setyapranata S, Holt SG. The Gut in Older Patients on Peritoneal Dialysis. Perit Dial Int. 2015 Nov;35(6):650-4. doi: 10.3747/pdi.2014.00341.

    PMID: 26702007BACKGROUND
  • Kosmadakis G, Albaret J, da Costa Correia E, Somda F, Aguilera D. Gastrointestinal Disorders in Peritoneal Dialysis Patients. Am J Nephrol. 2018;48(5):319-325. doi: 10.1159/000494145. Epub 2018 Oct 19.

    PMID: 30343294BACKGROUND
  • Cha RR, Park SY, Camilleri M; Constipation Research Group of Korean Society of Neurogastroenterology and Motility. Constipation in Patients With Chronic Kidney Disease. J Neurogastroenterol Motil. 2023 Oct 30;29(4):428-435. doi: 10.5056/jnm23133.

    PMID: 37814433BACKGROUND
  • Tian N, Li L, Ng JK, Li PK. The Potential Benefits and Controversies of Probiotics Use in Patients at Different Stages of Chronic Kidney Disease. Nutrients. 2022 Sep 29;14(19):4044. doi: 10.3390/nu14194044.

    PMID: 36235699BACKGROUND
  • Biruete A, Shin A, Kistler BM, Moe SM. Feeling gutted in chronic kidney disease (CKD): Gastrointestinal disorders and therapies to improve gastrointestinal health in individuals CKD, including those undergoing dialysis. Semin Dial. 2024 Jul-Aug;37(4):334-349. doi: 10.1111/sdi.13030. Epub 2021 Oct 27.

    PMID: 34708456BACKGROUND
  • Hamaguchi T, Tayama J, Suzuki M, Nakaya N, Takizawa H, Koizumi K, Amano Y, Kanazawa M, Fukudo S. The effects of locomotor activity on gastrointestinal symptoms of irritable bowel syndrome among younger people: An observational study. PLoS One. 2020 May 29;15(5):e0234089. doi: 10.1371/journal.pone.0234089. eCollection 2020.

    PMID: 32470098BACKGROUND
  • Bianco A, Russo F, Franco I, Riezzo G, Donghia R, Curci R, Bonfiglio C, Prospero L, D'Attoma B, Ignazzi A, Campanella A, Osella AR. Enhanced Physical Capacity and Gastrointestinal Symptom Improvement in Southern Italian IBS Patients following Three Months of Moderate Aerobic Exercise. J Clin Med. 2023 Oct 26;12(21):6786. doi: 10.3390/jcm12216786.

    PMID: 37959251BACKGROUND
  • Riezzo G, Prospero L, D'Attoma B, Ignazzi A, Bianco A, Franco I, Curci R, Campanella A, Bonfiglio C, Osella AR, Russo F. The Impact of a Twelve-Week Moderate Aerobic Exercise Program on Gastrointestinal Symptom Profile and Psychological Well-Being of Irritable Bowel Syndrome Patients: Preliminary Data from a Southern Italy Cohort. J Clin Med. 2023 Aug 17;12(16):5359. doi: 10.3390/jcm12165359.

    PMID: 37629401BACKGROUND
  • Zhang F, Liao J, Zhang W, Wang H, Huang L, Shen Q, Zhang H. Effects of Baduanjin Exercise on Physical Function and Health-Related Quality of Life in Peritoneal Dialysis Patients: A Randomized Trial. Front Med (Lausanne). 2021 Nov 29;8:789521. doi: 10.3389/fmed.2021.789521. eCollection 2021.

    PMID: 34912835BACKGROUND
  • Abdelbasset WK, Ibrahim AA, Althomali OW, Hussein HM, Alrawaili SM, Alsubaie SF. Effect of twelve-week concurrent aerobic and resisted exercise training in non-dialysis day on functional capacity and quality of life in chronic kidney disease patients. Eur Rev Med Pharmacol Sci. 2022 Sep;26(17):6098-6106. doi: 10.26355/eurrev_202209_29626.

    PMID: 36111910BACKGROUND
  • Weiner DE, Liu CK, Miao S, Fielding R, Katzel LI, Giffuni J, Well A, Seliger SL. Effect of Long-term Exercise Training on Physical Performance and Cardiorespiratory Function in Adults With CKD: A Randomized Controlled Trial. Am J Kidney Dis. 2023 Jan;81(1):59-66. doi: 10.1053/j.ajkd.2022.06.008. Epub 2022 Aug 6.

    PMID: 35944747BACKGROUND
  • Deus LA, Correa HL, Neves RVP, Reis AL, Honorato FS, Araujo TB, Souza MK, Haro AS, Silva VL, Barbosa JMDS, Padula IA, Andrade RV, Simoes HG, Prestes J, Stone WJ, Melo GF, Rosa TS. Metabolic and hormonal responses to chronic blood-flow restricted resistance training in chronic kidney disease: a randomized trial. Appl Physiol Nutr Metab. 2022 Feb;47(2):183-194. doi: 10.1139/apnm-2021-0409. Epub 2022 Jan 21.

    PMID: 35062832BACKGROUND
  • Li WY, Chiu FC, Zeng JK, Li YW, Huang SH, Yeh HC, Cheng BW, Yang FJ. Mobile Health App With Social Media to Support Self-Management for Patients With Chronic Kidney Disease: Prospective Randomized Controlled Study. J Med Internet Res. 2020 Dec 15;22(12):e19452. doi: 10.2196/19452.

    PMID: 33320101BACKGROUND
  • Gravina EPL, Pinheiro BV, da Silva Jesus LA, da Silva LP, da Silva RN, Silva K, de Paula RB, Reboredo MM. Effects of long-term aerobic training and detraining on functional capacity and quality of life in hemodialysis patients: A pilot study. Int J Artif Organs. 2020 Jun;43(6):411-415. doi: 10.1177/0391398819890622. Epub 2019 Nov 27.

    PMID: 31774015BACKGROUND
  • Bennett PN, Bohm C, Harasemiw O, Brown L, Gabrys I, Jegatheesan D, Johnson DW, Lambert K, Lightfoot CJ, MacRae J, Meade A, Parker K, Scholes-Robertson N, Stewart K, Tarca B, Verdin N, Wang AY, Warren M, West M, Zimmerman D, Li PK, Thompson S. Physical activity and exercise in peritoneal dialysis: International Society for Peritoneal Dialysis and the Global Renal Exercise Network practice recommendations. Perit Dial Int. 2022 Jan;42(1):8-24. doi: 10.1177/08968608211055290. Epub 2021 Nov 7.

    PMID: 34743628BACKGROUND
  • Bennett PN, Bohm C, Yee-Moon Wang A, Kanjanabuch T, Figueiredo AE, Harasemiw O, Brown L, Gabrys I, Jegatheesan D, Lambert K, Lightfoot CJ, MacRae J, Scholes-Robertson N, Stewart K, Tarca B, Verdin N, Warren M, West M, Zimmerman D, Finderup J, Ford E, Ribeiro HS, Xu Q, Thompson S. An International Survey of Peritoneal Dialysis Exercise Practices and Perceptions. Kidney Int Rep. 2023 May 3;8(7):1389-1398. doi: 10.1016/j.ekir.2023.04.024. eCollection 2023 Jul.

    PMID: 37441469BACKGROUND
  • Wu HHL, Poulikakos D, Hurst H, Lewis D, Chinnadurai R. Delivering Personalized, Goal-Directed Care to Older Patients Receiving Peritoneal Dialysis. Kidney Dis (Basel). 2023 Jun 23;9(5):358-370. doi: 10.1159/000531367. eCollection 2023 Oct.

    PMID: 37901709BACKGROUND
  • Eypasch E, Williams JI, Wood-Dauphinee S, Ure BM, Schmulling C, Neugebauer E, Troidl H. Gastrointestinal Quality of Life Index: development, validation and application of a new instrument. Br J Surg. 1995 Feb;82(2):216-22. doi: 10.1002/bjs.1800820229.

    PMID: 7749697BACKGROUND
  • Heine GH, Kastner CY, Jahnke T, Kohler H, Kuhlmann MK. Does a history of peritoneal dialysis result in an impaired gastrointestinal life quality? Hemodial Int. 2007 Oct;11(4):461-7. doi: 10.1111/j.1542-4758.2007.00218.x.

    PMID: 17922745BACKGROUND
  • Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998 Jan;7(1):75-83. doi: 10.1023/a:1008841022998.

    PMID: 9481153BACKGROUND
  • Frank L, Kleinman L, Farup C, Taylor L, Miner P Jr. Psychometric validation of a constipation symptom assessment questionnaire. Scand J Gastroenterol. 1999 Sep;34(9):870-7. doi: 10.1080/003655299750025327.

    PMID: 10522604BACKGROUND
  • Aya V, Jimenez P, Munoz E, Ramirez JD. Effects of exercise and physical activity on gut microbiota composition and function in older adults: a systematic review. BMC Geriatr. 2023 Jun 12;23(1):364. doi: 10.1186/s12877-023-04066-y.

    PMID: 37308839BACKGROUND
  • Boytar AN, Skinner TL, Wallen RE, Jenkins DG, Dekker Nitert M. The Effect of Exercise Prescription on the Human Gut Microbiota and Comparison between Clinical and Apparently Healthy Populations: A Systematic Review. Nutrients. 2023 Mar 22;15(6):1534. doi: 10.3390/nu15061534.

    PMID: 36986264BACKGROUND

MeSH Terms

Conditions

Motor ActivityRenal Insufficiency, Chronic

Interventions

Exercise

Condition Hierarchy (Ancestors)

BehaviorRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jin Chen, Doctor

    Sichuan Academy of Medical Sciences , University of Electronic Science and Technology of China,

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Renjing Yang, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

April 7, 2024

First Posted

April 16, 2024

Study Start

March 1, 2024

Primary Completion

June 30, 2025

Study Completion

December 31, 2025

Last Updated

April 16, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations